The Injective community has overwhelmingly approved a governance proposal that pushes INJ into a sharper deflationary trajectory, cutting long-term supply by changing the protocol’s issuance rules.
Key vote details
- The proposal (IIP-617) closed on Jan. 19 after a four-day vote, earning 99.89% support from participating voters. Injective Foundation members publicly disclosed they voted in favor.
What changes
- The update tightens INJ’s inflation parameters so new token issuance falls more quickly. Existing token burn mechanisms will remain in place.
- The change acts directly at the protocol level to reduce supply issuance rather than creating a new buyback program. It will work alongside the existing Injective Community BuyBack, which uses ecosystem revenue to buy INJ on the open market and burn it regularly.
Context and history
- Injective (INJ) is the network’s native asset used to secure the chain and coordinate ecosystem activity. Since mainnet launch the protocol has employed recurring burns—about 6.85 million INJ have been permanently removed so far.
- IIP-617 builds on the broader INJ 3.0 series of updates. In 2024, IIP-392 increased deflationary pressure by 400% and tied some policy levers to staking levels. Subsequent adjustments linked further supply reductions to Bitcoin’s halving cycle, stretching contraction over multiple years. The new vote tightens those parameters again, effectively embedding stronger deflation into the protocol rather than leaving it dependent on market conditions or network usage.
Market reaction and outlook
- Despite the more restrictive issuance schedule and multiple deflationary levers now active (burns + buybacks + lower issuance), INJ has remained volatile through 2025 and into early 2026. The token is still down roughly 75% from a year ago, prompting caution from some traders.
- Injective’s changes increase the protocol-level cap on new supply, but short-term price action is likely to remain influenced by broader crypto market sentiment as much as by tokenomics shifts.
Bottom line
- With near-unanimous governance backing, Injective has moved to harden INJ’s deflationary profile by cutting issuance at the source. Whether that will translate into sustained price support depends on broader market conditions and adoption metrics as Deflationary mechanics now sit more firmly inside the protocol’s design.
Read more AI-generated news on: undefined/news
